Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:e53-e55
Published online before print May 12, 2005, doi: 10.1161/01.STR.0000166203.27135.27
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/6/e53    most recent
01.STR.0000166203.27135.27v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, D. M.
Right arrow Articles by Weinberger, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Johnson, D. M.
Right arrow Articles by Weinberger, J.
Related Collections
Right arrow Embolic stroke
Right arrow Angiography
Right arrow Thrombolysis

(Stroke. 2005;36:e53.)
© 2005 American Heart Association, Inc.


Case Reports

Thrombolytic Therapy for Acute Stroke in Late Pregnancy With Intra-Arterial Recombinant Tissue Plasminogen Activator

David M. Johnson, MD; David C. Kramer, MD; Ezra Cohen, MD; Meredith Rochon, MD; Mara Rosner, MD Jesse Weinberger, MD

From the Departments of Neurosurgery, Radiology, Anesthesiology, Neurology, Obstetrics, Gynecology, and Reproductive Science, Mount Sinai Medical Center, New York, NY.

Correspondence to David C. Kramer, Mount Sinai Medical Center, 1 Gustave L. Levy Place, Box 1136, New York, NY 10029-6574. E-mail dkrame01{at}msnyuhealth.org

Abstract

Background and Purpose— The most common presentation of ischemic stroke related to pregnancy is arterial occlusion, occurring during the third trimester or postpartum. The authors present the first successful administration of intra-arterial cerebral tissue plasminogen activator to treat an embolic cerebral vascular accident in a 37-week parturient resulting in complete recovery of neurological function.

Methods— The patient presented with left hemiplegia, left-sided neglect, and aphasia. Right internal carotid artery cerebral angiogram showed occlusion of the mid-M1 segment of the middle cerebral artery (MCA). After 15 mg of tissue plasminogen activator was administered via intra-arterial route, there was greatly improved retrograde flow through the posterior communication artery and the MCA territory.

Results— A reduction in size of the MCA occlusion was noted with improvement of antegrade flow through the MCA. Three days after the procedure, the patient was induced successfully and delivered a healthy infant vaginally.

Conclusion— This report describes the use of intra-arterial tissue plasminogen activator in the setting of stroke in late pregnancy.


Key Words: cerebral angiography • cerebral infarction • thrombolytic therapy • tissue plasminogen activator